Skip to content

Latest disclosed trades

Every stock trade disclosed by members of Congress, the executive branch and company insiders — newest first.

See the trades

Updated Oct 17 · 2 feeds behind: Insider filings, 3 days, and 1 more · Every feed →

All 33Congress 0Executive branch 0Insiders 33
AllBuysSells
Filed late
More filters
DemRepInd
HouseSenateExecutive
$15K+$50K+$100K+$250K+$1M+
Clear filters

PBLS · $1M+ · 33 trades

Trades
33
Buys 33 · Sells 0
People
14
Stocks
1
Disclosed value
$116M
range midpoints · Congress & executive
Filed late
18
  1. ▲ BUYRA Capital Nexus Fund III, L.P. DirectorPBLS Parabilis Medicines, Inc.$1.1Mdisclosed Jul 22 · filed 1 day after the trade
  2. ▲ BUYRA Capital Healthcare Fund LP DirectorPBLS Parabilis Medicines, Inc.$1.1Mdisclosed Jul 22 · filed 1 day after the trade
  3. ▲ BUYRa Capital Management, L.P. DirectorPBLS Parabilis Medicines, Inc.$2.7Mdisclosed Jul 22 · filed 2 days after the trade
  4. ▲ BUYRa Capital Management, L.P. DirectorPBLS Parabilis Medicines, Inc.$1.1Mdisclosed Jul 22 · filed 1 day after the trade
  5. ▲ BUYRA Capital Nexus Fund III, L.P. DirectorPBLS Parabilis Medicines, Inc.$1.4Mdisclosed Jul 22 · filed the same day
  6. ▲ BUYRajeev M. Shah DirectorPBLS Parabilis Medicines, Inc.$2.7Mdisclosed Jul 22 · filed 2 days after the trade
  7. ▲ BUYPeter Kolchinsky DirectorPBLS Parabilis Medicines, Inc.$1.1Mdisclosed Jul 22 · filed 1 day after the trade
  8. ▲ BUYRA Capital Healthcare Fund LP DirectorPBLS Parabilis Medicines, Inc.$1.4Mdisclosed Jul 22 · filed the same day
  9. ▲ BUYRA Capital Nexus Fund III, L.P. DirectorPBLS Parabilis Medicines, Inc.$2.7Mdisclosed Jul 22 · filed 2 days after the trade
  10. ▲ BUYRajeev M. Shah DirectorPBLS Parabilis Medicines, Inc.$1.1Mdisclosed Jul 22 · filed 1 day after the trade
  11. ▲ BUYPeter Kolchinsky DirectorPBLS Parabilis Medicines, Inc.$2.7Mdisclosed Jul 22 · filed 2 days after the trade
  12. ▲ BUYRA Capital Healthcare Fund LP DirectorPBLS Parabilis Medicines, Inc.$2.7Mdisclosed Jul 22 · filed 2 days after the trade
  13. ▲ BUYRa Capital Management, L.P. DirectorPBLS Parabilis Medicines, Inc.$1.4Mdisclosed Jul 22 · filed the same day
  14. ▲ BUYRajeev M. Shah DirectorPBLS Parabilis Medicines, Inc.$1.4Mdisclosed Jul 22 · filed the same day
  15. ▲ BUYPeter Kolchinsky DirectorPBLS Parabilis Medicines, Inc.$1.4Mdisclosed Jul 22 · filed the same day
  16. ▲ BUYSoleus Capital Group, LLC 10% ownerPBLS Parabilis Medicines, Inc.$2.5Mdisclosed Jun 29 · filed 18 days after the trade · late
  17. ▲ BUYSoleus Capital, LLC 10% ownerPBLS Parabilis Medicines, Inc.$7.5Mdisclosed Jun 29 · filed 18 days after the trade · late
  18. ▲ BUYSoleus Capital Management, L.P. 10% ownerPBLS Parabilis Medicines, Inc.$7.5Mdisclosed Jun 29 · filed 18 days after the trade · late
  19. ▲ BUYSoleus Private Equity GP III, LLC 10% ownerPBLS Parabilis Medicines, Inc.$2.5Mdisclosed Jun 29 · filed 18 days after the trade · late
  20. ▲ BUYSoleus GP, LLC 10% ownerPBLS Parabilis Medicines, Inc.$2.5Mdisclosed Jun 29 · filed 18 days after the trade · late
  21. ▲ BUYGuy Levy 10% ownerPBLS Parabilis Medicines, Inc.$7.5Mdisclosed Jun 29 · filed 18 days after the trade · late
  22. ▲ BUYSoleus PE GP III, LLC 10% ownerPBLS Parabilis Medicines, Inc.$2.5Mdisclosed Jun 29 · filed 18 days after the trade · late
  23. ▲ BUYSoleus Capital Group, LLC 10% ownerPBLS Parabilis Medicines, Inc.$7.5Mdisclosed Jun 29 · filed 18 days after the trade · late
  24. ▲ BUYSoleus Capital Management, L.P. 10% ownerPBLS Parabilis Medicines, Inc.$2.5Mdisclosed Jun 29 · filed 18 days after the trade · late
  25. ▲ BUYSoleus Capital Master Fund, L.P. 10% ownerPBLS Parabilis Medicines, Inc.$2.5Mdisclosed Jun 29 · filed 18 days after the trade · late